µÚ64½ìÃÀ¹úѪҺѧ»á(American Society of Hematology£¬£¬£¬£¬£¬£¬£¬ASH)Äê»á½«ÓÚ2022Äê12ÔÂ10ÈÕ-13ÈÕÔÚÃÀ¹úа¶ûÁ¼¾ÙÐС£¡£¡£¡£¡£¡£¡£º²É­ÖÆÒ©Á¢ÒìÒ©ºÀɭ꿸£^?(¼×»ÇËá·úÂíÌæÄáƬ)µÄ×îÐÂÁÙ´²Ñо¿Ð§¹û£¬£¬£¬£¬£¬£¬£¬½«ÒÔPoster¿ÚÍ·±¨¸æÐÎʽչʾ£¬£¬£¬£¬£¬£¬£¬´ú±íÁ˹ú¼ÊȨÍþר¼Ò¶ÔÖйú×ÔÖ÷Ñз¢µÄ¶þ´úTKI·úÂíÌæÄáÔÚ³õ·¢ph+ALLÁÆЧºÍÇå¾²ÐԵĸ߶ÈÈÏ¿É¡£¡£¡£¡£¡£¡£¡£

×÷ΪÊ×ÆäÖйúÔ­ÑÐÐÂÐͶþ´úÀÒ°±ËἤøÒÖÖƼÁ(TKI)£¬£¬£¬£¬£¬£¬£¬ºÀɭ꿸£^?ÖÎÁÆÂýÐÔÆÚÂýÐÔËèÐÔ°×Ѫ²¡ÔÚÁÆЧºÍÇå¾²ÐÔÉÏʵÏÖ¡°Ë«ÏòÓÅ»¯¡±£¬£¬£¬£¬£¬£¬£¬·´Ó¦Âʸü¸ß£¬£¬£¬£¬£¬£¬£¬·´Ó¦¸ü¿ì¸üÉ£¬£¬£¬£¬£¬£¬ÄÍÊÜÐÔ¸üºÃ£¬£¬£¬£¬£¬£¬£¬³ÉΪÁÙ´²ÓÅÑ¡¡°¶þ´ú+TKI¡±¡£¡£¡£¡£¡£¡£¡£2019ÄêÉÏÊÐÒÔÀ´£¬£¬£¬£¬£¬£¬£¬»¼Õß»ñÒæÏÔ×Å£¬£¬£¬£¬£¬£¬£¬ºã¾ÃʹÓû¼ÕßÈËȺһÁ¬ÔöÌí¡£¡£¡£¡£¡£¡£¡£

ÕªÒªºÅ£ºPOSTER 4049

·úÂíÌæÄáÍŽữÁÆÖÎÁÆÐÂÕï¶ÏµÄPh/BCR-ABL1ÑôÐÔ³ÉÈ˼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡µÄIIÆÚÑо¿:RJ-ALL2020.2AÊÔÑéµÄÆðԴЧ¹û

Leading PI£ºÃÓ¼áÇà Íõèª ÉϺ£½»Í¨´óѧҽѧԺÁ¥ÊôÈð½ðÒ½Ôº

Ñо¿Åä¾°£ºÀÒ°±ËἤøÒÖÖƼÁ(TKIs)ÏÔÖø¸ÄÉÆÁËPh/BCR-ABL1ÑôÐÔ(Ph/BCR-ABL1+)¼±ÐÔÁÜ°Íϸ°û°×Ѫ²¡(ALL)»¼ÕßµÄÁÙ´²Ô¤ºó¡£¡£¡£¡£¡£¡£¡£Óë1´úTKIÏà±È£¬£¬£¬£¬£¬£¬£¬2´úTKIÖÎÁƺóÕ¹ÏÖ³ö¸üºÃµÄÖÎÁÆÓ¦´ðÂʺʹæ»îÂÊ¡£¡£¡£¡£¡£¡£¡£×÷ΪһÖÖÐÂÐÍ2´úTKI£¬£¬£¬£¬£¬£¬£¬·úÂíÌæÄáÒÑÓÚ2019ÄêÔÚÖйú»ñµÃÅú×¼ÉÏÊС£¡£¡£¡£¡£¡£¡£ÔÚÂýÐÔÁ£Ï¸°û°×Ѫ²¡(CML)»¼ÕßµÄÁÙ´²ÊÔÑéÖУ¬£¬£¬£¬£¬£¬£¬·úÂíÌæÄáÒÑÏÔʾ³ö±ÈÒÁÂíÌæÄá¸üºÃµÄÁÆЧ£¬£¬£¬£¬£¬£¬£¬µ«ÔÚALL»¼ÕßÖеı¨µÀÈ´ÁÈÈô³¿ÐÇ¡£¡£¡£¡£¡£¡£¡£RJ-ALL2020.2AÊÔÑéÊÇÊ׸öÓÚ¹ú¼ÊÉϱ¨µÀµÄ·úÂíÌæÄáÓ¦ÓÃÓÚPh/BCR-ABL1+ ALLµÄ×¢²áÁÙ´²ÊÔÑ飬£¬£¬£¬£¬£¬£¬Ö¼ÔÚÆÀ¹À¸ÃÒ©ÔÚ³ÉÈË»¼ÕßÖеÄÓÐÓÃÐÔºÍÇå¾²ÐÔ¡£¡£¡£¡£¡£¡£¡£

      Ñо¿Ð§¹û£º´Ó2020Äê12Ôµ½2022Äê6Ô£¬£¬£¬£¬£¬£¬£¬Ñо¿¹²ÄÉÈë44Àý³õÕïµÄPh/BCR-ABL1+ ALL»¼Õß¡£¡£¡£¡£¡£¡£¡£»£»£»£»£»¼ÕßÖÐλÄêËêΪ44Ëê(ÄêËê¹æÄ£,19-63Ëê)£¬£¬£¬£¬£¬£¬£¬ÖÐλ°×ϸ°û¼ÆÊýΪ39.9¡Á109/L(¹æÄ£0.6-675.3¡Á109/L)¡£¡£¡£¡£¡£¡£¡£ÆäÖУ¬£¬£¬£¬£¬£¬£¬4Àý»¼Õß±£´æÔ­·¢ÐÔÖÐÊàÉñ¾­ÏµÍ³°×Ѫ²¡¡£¡£¡£¡£¡£¡£¡£

ÔÚÁÆЧЧ¹û·½Ã棬£¬£¬£¬£¬£¬£¬ÓÕµ¼ÖÎÁÆÀú³ÌÖÐûÓзºÆðÔçÆÚéæÃü²¡Àý£¬£¬£¬£¬£¬£¬£¬41Àý»¼Õß(93.2%)ÔÚÓÕµ¼¿¢ÊÂʱµÖ´ïÍêÈ«»º½â(CR)¡£¡£¡£¡£¡£¡£¡£ÔÚÓÕµ¼¿¢ÊºÍ3¸öÔÂʱ£¬£¬£¬£¬£¬£¬£¬¾­MFCÆÀ¹ÀµÄMRDneg(<0.01%)ÂÊ»®·ÖΪ65.9%(27/41)ºÍ76.9%(30/39)£¬£¬£¬£¬£¬£¬£¬ÍêÈ«·Ö×ÓÉúÎïѧ»º½â(CMR)ÂÊ»®·ÖΪ35%(14/40)ºÍ50%(19/38)¡£¡£¡£¡£¡£¡£¡£Ñо¿µÄÖÐλËæ·Ãʱ¼äΪ10¸öÔÂ(¹æÄ££¬£¬£¬£¬£¬£¬£¬1-16¸öÔÂ)£¬£¬£¬£¬£¬£¬£¬Ô¤¼ÆµÄ1ÄêPFSÂʺÍOSÂÊ»®·ÖΪ79.9%ºÍ90.3%¡£¡£¡£¡£¡£¡£¡£ÔÚ41Àý´æ»î»¼ÕßÖУ¬£¬£¬£¬£¬£¬£¬34ÀýÌåÏÖΪһÁ¬»º½â£¬£¬£¬£¬£¬£¬£¬2ÀýΪÄÑÖÎÐÔ»¼Õߣ¬£¬£¬£¬£¬£¬£¬5Àý·ºÆð¼²²¡¸´·¢¡£¡£¡£¡£¡£¡£¡£ÔÚ3ÀýéæÃü»¼ÕßÖУ¬£¬£¬£¬£¬£¬£¬2ÀýËÀÓÚ¼²²¡Ï£Íû£¬£¬£¬£¬£¬£¬£¬1ÀýËÀÓÚHSCTºóµÄ·Î²¿Ñ¬È¾¡£¡£¡£¡£¡£¡£¡£24Àý»¼Õß½ÓÊÜallo-HSCT£¬£¬£¬£¬£¬£¬£¬´ÓÕï¶Ïµ½½ÓÊÜÒÆÖ²µÄÖÐλʱ¼äΪ6¸öÔÂ(¹æÄ££¬£¬£¬£¬£¬£¬£¬3-10¸öÔÂ)(12ÀýΪ°ëÏàºÏÒÆÖ²£¬£¬£¬£¬£¬£¬£¬12ÀýΪȫÏàºÏÒÆÖ²)£¬£¬£¬£¬£¬£¬£¬ÖÐλÄêËêΪ38Ëê(¹æÄ££¬£¬£¬£¬£¬£¬£¬20-60Ëê)¡£¡£¡£¡£¡£¡£¡£ÔÚHSCTÇ°£¬£¬£¬£¬£¬£¬£¬MRDnegÂÊΪ75%(18/24)£¬£¬£¬£¬£¬£¬£¬CMRÂÊΪ66.7%(16/24)¡£¡£¡£¡£¡£¡£¡£½ÓÊÜHSCTµÄ»¼Õß¾ßÓÐÏà¶Ô¸üºÃµÄÔ¤ºó£¬£¬£¬£¬£¬£¬£¬ÔÚ1ÄêPFSÂÊ·½ÃæÏÔןßÓÚ·ÇHSCT×é(95.7%vs.52.2%, p=0.006)£¬£¬£¬£¬£¬£¬£¬ÔÚ1ÄêOSÂÊ·½ÃæÒ²Ç÷ÓÚ¸ü¸ß(100% vs.74.1%£¬£¬£¬£¬£¬£¬£¬p=0.145)¡£¡£¡£¡£¡£¡£¡£ÔÚ40Àý¿ÉÆÀ¹ÀABL1Í»±äµÄ»¼ÕßÖУ¬£¬£¬£¬£¬£¬£¬ÓÐ14Àý»¼Õß±¬·¢ÁËÍ»±ä£¬£¬£¬£¬£¬£¬£¬ÆäÖÐT315I×î³£¼û£¬£¬£¬£¬£¬£¬£¬Õ¼±È¸ß´ï71%, Æä´ÎÊÇY253H(29%), E255V(14%), E255K(7%), T267A(7%)¡£¡£¡£¡£¡£¡£¡£T315IÍ»±ä»¼Õ߱ȷÇT315IÍ»±ä(ÎÞÍ»±ä»òÆäËûÍ»±ä)µÄÔ¤ºó¸ü²î£¬£¬£¬£¬£¬£¬£¬1ÄêPFSÂÊ»®·ÖΪ0%ºÍ100%(p<0.001)£¬£¬£¬£¬£¬£¬£¬1ÄêosÂÊ»®·ÖΪ55.6%ºÍ100%(p=0.06)¡£¡£¡£¡£¡£¡£¡£< p="">

ͬʱ£¬£¬£¬£¬£¬£¬£¬·úÂíÌæÄáÍŽữÁƵÄÄÍÊÜÐÔÓÅÒì¡£¡£¡£¡£¡£¡£¡£3-4¼¶²»Á¼ÊÂÎñ¶àÒÔѪҺϵͳΪÖ÷£¬£¬£¬£¬£¬£¬£¬Õâ¿ÉÄÜÓëÓÕµ¼»¯ÁÆÓйء£¡£¡£¡£¡£¡£¡£ÆäËû¸±×÷ÓÃÈç賦µÀÖ¢×´ºÍ¸Î¶¾ÐÔ½öΪ1-2¼¶£¬£¬£¬£¬£¬£¬£¬²¢ÇÒÔÚ¶ÔÖ¢´¦Öóͷ£ºó¿ÉºÜ¿ì»Ö¸´Õý³£¡£¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬£¬Ã»Óл¼ÕßÒò·ºÆðÑÏÖض¾ÐÔ·´Ó¦¶øÍ£Ó÷úÂíÌæÄá¡£¡£¡£¡£¡£¡£¡£

       Ñо¿½áÂÛ£º2´úTKI·úÂíÌæÄáÍŽữÁÆÓÃÓÚÖÎÁƳõ·¢µÄÖйú³ÉÈËPh/BCR-ABL1+ ALL»¼ÕßÕ¹ÏÖ³öÓÅÒìµÄÓÐÓÃÐÔºÍÇå¾²ÐÔ¡£¡£¡£¡£¡£¡£¡£¸ÃÁÙ´²ÊÔÑéÈÔÔÚ¾ÙÐÐÖУ¬£¬£¬£¬£¬£¬£¬ºã¾ÃËæ·ÃÊý¾Ý½«Óдý½øÒ»²½ÊӲ졣¡£¡£¡£¡£¡£¡£